0000899243-22-016635.txt : 20220504
0000899243-22-016635.hdr.sgml : 20220504
20220504170722
ACCESSION NUMBER: 0000899243-22-016635
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220502
FILED AS OF DATE: 20220504
DATE AS OF CHANGE: 20220504
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WAGNER CHARLES F JR
CENTRAL INDEX KEY: 0001223348
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 22892502
MAIL ADDRESS:
STREET 1: C/O MILLIPORE CORP
CITY: BILLERICA
STATE: MA
ZIP: 01820
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-02
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001223348
WAGNER CHARLES F JR
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP & Chief Financial Officer
Common Stock
2022-05-02
4
S
0
20
254.87
D
43053
D
Common Stock
2022-05-02
4
S
0
100
257.18
D
42953
D
Common Stock
2022-05-02
4
S
0
60
258.21
D
42893
D
Common Stock
2022-05-02
4
S
0
80
259.45
D
42813
D
Common Stock
2022-05-02
4
S
0
48
261.15
D
42765
D
Common Stock
2022-05-02
4
S
0
32
262.06
D
42733
D
Common Stock
2022-05-02
4
S
0
3
264.37
D
42730
D
Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1.
Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $257.18 (range $256.68 to $257.47).
Open market sales reported on this line occurred at a weighted average price of $258.21 (range $257.98 to $258.61).
Open market sales reported on this line occurred at a weighted average price of $259.45 (range $258.98 to $259.90).
Open market sales reported on this line occurred at a weighted average price of $261.15 (range $260.79 to $261.63).
Open market sales reported on this line occurred at a weighted average price of $262.06 (range $261.89 to $262.23).
/s/ Sabrina Yohai, Attorney-in-Fact
2022-05-04